Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:acquiredBy |
gptkb:CRYOPDP
gptkb:MVE_Biological_Solutions CRYOGENE |
| gptkbp:CEO |
gptkb:Jerrell_Shelton
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:foundedYear |
1999
|
| gptkbp:fullName |
Cryoport, Inc.
|
| gptkbp:headquartersLocation |
gptkb:Brentwood,_Tennessee,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
CYRX
|
| gptkbp:industry |
gptkb:biotechnology
logistics |
| gptkbp:marketCap |
over $500 million (as of 2023)
|
| gptkbp:numberOfEmployees |
over 700
|
| gptkbp:servesIndustry |
gptkb:biotechnology
pharmaceuticals reproductive medicine cell and gene therapy |
| gptkbp:specializesIn |
temperature-controlled logistics
supply chain solutions for life sciences |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:CYRX
|
| gptkbp:tickerType |
equity
|
| gptkbp:website |
https://www.cryoport.com/
|
| gptkbp:bfsParent |
gptkb:Cryoport
|
| gptkbp:bfsLayer |
8
|